XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1Close
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Operating activities    
Net earnings $ 3,200 $ 11,431
Noncash items:    
Depreciation and amortization 2,017 1,991
Deferred income taxes (358) (482)
Share-based compensation 594 604
Loss on sale of subsidiary and subsidiaries held for sale (8,311) 0
Other, net 459 (91)
Net change in other operating items, net of effects from acquisitions, dispositions and changes in AARP balances:    
Accounts receivable (2,471) 197
Other assets (4,121) (2,001)
Medical costs payable 777 2,408
Accounts payable and other liabilities 36 1,547
Unearned revenues (554) 11,755
Cash flows from operating activities 7,890 27,359 CloseClose
Investing activities    
Purchases of investments (10,130) (9,225)
Sales of investments 5,288 3,188
Maturities of investments 4,621 4,463
Cash paid for acquisitions, net of cash assumed (3,031) (8,161)
Purchases of property, equipment and capitalized software (1,596) (1,589)
Loans to providers - cyberattack (8,100) 0
Other, net (809) (424)
Cash flows used for investing activities (13,757) (11,748) CloseClose
Financing activities    
Common share repurchases (3,072) (5,000)
Cash dividends paid (3,664) (3,284)
Proceeds from common stock issuances 744 628
Repayments of long-term debt (1,750) (2,125)
Proceeds from short-term borrowings, net 8,615 3,426
Proceeds from issuance of long-term debt 5,925 6,394
Customer funds administered 990 4,069
Other, net (753) (1,377)
Cash flows from financing activities 7,035 2,731 CloseClose
Effect of exchange rate changes on cash and cash equivalents (44) 106 CloseClose
Increase in cash and cash equivalents, including cash within businesses held for sale 1,124 18,448
Less: cash within businesses held for sale (265) 0
Net increase in cash and cash equivalents 859 18,448 CloseClose
Cash and cash equivalents, beginning of period 25,427 23,365
Cash and cash equivalents, end of period $ 26,286 $ 41,813